Tag Archive for: Investor

Optimum’s hot topic: Investors look ahead to ’25 at London Life Sciences Week

By Richard Staines London Life Sciences Week has become a major fixture on the biotech calendar with two conferences – the LSX Inve$tival and the Jefferies London Healthcare Conference – plus the LSX Lifestars Awards all falling within one working week.  This year’s Jefferies event expanded from its traditional home at the Waldorf Astoria Hotel […]

Optimum Strategic Communications to Host 16th Annual Healthcare Investor Conference with ‘Back to Growth’ theme

LONDON, Oct. 8, 2024 /PRNewswire/ — Optimum Strategic Communications (Optimum), the international strategic healthcare communications consultancy, will be hosting its 16th Annual Healthcare Investor Conference on Thursday 10 October, 2024 at The Kings Fund, London. This year, as markets begin to bounce back after a lacklustre period, a prestigious line-up of industry experts will look to growth, identifying which therapies will attract investor […]

Resolution Therapeutics Announces £63.5 Million Series B Financing and Chair Appointment

Financing to advance lead asset RTX001, an engineered, pro-regenerative macrophage therapy with first-in-class potential for end-stage liver disease, into the Phase I/II EMERALD study Proceeds also strengthen manufacturing capabilities and support macrophage therapy pipeline growth in inflammatory and fibrotic indications beyond liver disease Paul Sekhri, seasoned life sciences executive with decades of drug development and […]

Weekly wrap-up: $100m Series B financing for a bivalent vaccine, to new clinical data from a cutting-edge antibody-drug conjugate…

Vicebio Announces $100 Million Series B Financing and Initiation of Phase 1 Clinical Study of RSV/hMPV Bivalent Vaccine  Vicebio Ltd, a biopharmaceutical company developing novel vaccines against life-threatening respiratory viral infections, on Monday announced a $100 million Series B financing  led by TCGX  with investment from Goldman Sachs Alternatives, Avoro Ventures, venBio,  and participation from UniQuest and founding investor Medicxi.  London-based Vicebio said funding […]